RE:RE:RE:RE:RE:RE:RE:RE:RE:Buyout numbers
My motives are to get this company off their behinds and do the things they say they are going to do like add the shareholder value they constantly talk about and to show some integrity and that they are aligned with the shareholders. The SP says it all right now and no denying that and as for accelerated approval, well we don't have that yet and remember the company says we anticipate starting the panc phase 3 in mid 2024 so there would be no accelerated approval until after that gets up and running and some results so now we are looking into 2025 so as that may be a good thing for sure we once again are looking 2 years away so what would be wrong with a 2 billion dollar buyout now. They can anticipate all they want but all of their anticipation in the last 7 years as not added anything YET to shareholder value and things keep getting pushed back which allows for new therapies to be in the forefront and even the company admitted to using the wrong choice of the CI in the bracelet trial and the people involved said that it was a possible expected outcome...that is not making a good business decision when they had success with the CI in the aware 1 trial so why would you switch with something that was actually showing success.. Shall we go on. And now Bracelet has shown that they will run the same trial with the same or more number of patients so exactly how much time and money has that saved the company and now we have another company that might set the new standard for the mbc...How is this all a good thing. Everything is not perfect with the company as some might suggest and not even close. They now need to prove that and the only way to prove that to shareholders is to get any phase 3 trial running and a partner on board and that has not happened.